AzTrials
AzTrials

Syncope, VasovagalNCT03159156

Respiration and Applied Tension Strategies to Reduce Vasovagal Reactions to Blood Donation

A study testing Applied Tension in people with Syncope, Vasovagal, run by McGill University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

For a number of years, researchers have examined the effects of the muscle-tensing technique, Applied Tension (AT), on blood donation-related vasovagal symptoms and donor retention. AT was developed originally to reduce symptoms and avoidance behaviour in people with strong fears of blood and needles (phobics). Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
Conditions the study is for
Syncope, Vasovagal
What is being tested?
Applied Tension
Could I receive a placebo?
No, everyone receives an active treatment
How many people
408 participants
Where
1 siteCanada
Study dates
15 Sep 2015to 31 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy volunteer blood donors.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Blaine Ditto, PhD contact

514-398-6097

blaine.ditto@mcgill.ca

Canada1 site, 1 recruiting
  • McGill University

    Montreal, Quebec, H3A1B1

    Blaine Ditto, PhD, 514-398-6097, blaine.ditto@mcgill.ca

    Recruiting

Other trials in Canada

About this study

For a number of years, researchers have examined the effects of the muscle-tensing technique, Applied Tension (AT), on blood donation-related vasovagal symptoms and donor retention. AT was developed originally to reduce symptoms and avoidance behaviour in people with strong fears of blood and needles (phobics). It was based on the idea that exercise-related increases in blood pressure might be able to counteract the effects of stimuli that lead to a decrease in delivery of blood to the brain. AT was adapted for non-phobic blood donors and significant reductions in self-reported vasovagal symptoms and the need for nurse-initiated treatment as well as increases in donor retention were observed in some groups.

That said, individual response to AT is quite variable. This is probably related to recent research indicating that exercise-related maintenance of heart rate and blood pressure plays only a minor role in reducing vasovagal symptoms. Rather, AT appears to be working at least in part by regulating breathing and reducing the possibility of hyperventilation. Pilot results suggest that a novel intervention aimed specifically at breathing may be more effective and reliable than traditional AT. To evaluate this idea, 408 blood donors at mobile clinics in colleges and universities will be assigned randomly to four conditions. In brief, 5-minute preparation sessions using a notebook computer, donors will either learn a respiration control technique to avoid hyperventilation, AT, both, or neither. As a manipulation check and also a means of examining mechanisms of the interventions, e.g., the possibility that AT may work by regulating breathing and CO2, participants will wear non-invasive portable capnometers while they are giving blood. Outcome will also be assessed by self-report of vasovagal symptoms, observational data, and number of return visits to a blood clinic in the following year verified by the provincial blood collection agency, Héma-Québec. As a secondary aim, the research will examine possible moderating effects of pre-donation anxiety and sex.

The development of simple, effective approaches to reduce vasovagal symptoms during blood donation has the potential to improve the blood donation experience and blood donor retention as well as encourage people who have never given blood to consider the procedure. It will also improve medical and dental care more generally given the use of needles in so many procedures.

Read the detailed description

See above.

Being tested
Applied Tension, Respiration Control, Applied Tension/Respiration Control
Medical subject headings
Syncope, Vasovagal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Applied TensionBehavioural

    Described above.

  • Respiration ControlBehavioural

    Described above.

  • Applied Tension/Respiration ControlBehavioural

    Described above.

Study groups in NCT03159156
Study groupRoleWhat they receive
Blood Donation As UsualNo interventionVolunteer blood donors complete assessment materials, including assessment of respiratory activity, but otherwise undergo the typical blood donation procedure.
Applied TensionExperimentalParticipants are taught a simple muscle tensing technique with a brief video presented on a notebook computer before giving blood. They are asked to engage in repeated gentle 5-sec on, 5-sec off cycles of whole body isometric muscle tension before and while giving blood.
Receives: Behavioral: Applied Tension
Respiration ControlExperimentalParticipants are taught a simple respiration control technique with a brief video presented on a notebook computer before giving blood. They are asked to breathe in a gentle shallow but regular fashion aimed at reducing risk for hyperventilation before and while giving blood.
Receives: Behavioral: Respiration Control
Applied Tension/Respiration ControlExperimentalParticipants are asked to practice both Applied Tension and Respiration Control before and while giving blood.
Receives: Behavioral: Applied Tension/Respiration Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in End Tidal CO2

    assessed by ambulatory monitor (capnometer)

    Measured: change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes)

  2. Change in Respiration Rate

    assessed by ambulatory monitor (capnometer)

    Measured: change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes)

  3. Blood Donation Reactions Inventory

    questionnaire assessing presyncopal vasovagal symptoms

    Measured: completed in the recovery area, approximately 15 minutes after blood donation

  4. Research Assistant Observations

    participant anxiety, fainting, whether or not treatment for a vasovagal response required, etc., noted by a research assistant

    Measured: during blood donation

Secondary outcomes (6)
  1. Change in Spielberger State Anxiety Scale Score

    self-report questionnaire

    Measured: completed just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in anxiety

  2. Medical Fears Survey

    self-report questionnaire

    Measured: completed in the recovery area, approximately 15 minutes after blood donation

  3. Change in Systolic Blood Pressure

    in mmHg

    Measured: measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure

  4. Change in Diastolic Blood Pressure

    in mmHg

    Measured: measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in blood pressure

  5. Change in Heart Rate

    in bpm

    Measured: measured just after registering at the clinic and also in the recovery area, approximately 15 minutes after blood donation, to assess change in heart rate

  6. Blood Donor Return

    number of times the donor returns to give blood again in a one-year time frame as reported by Hema-Quebec

    Measured: one year after participating in the study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2017
  2. Study start15 Sep 2015
  3. Primary completion31 May 2018 (estimated)
  4. Study completion31 May 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Factorial
Model description
The primary goal is to examine the role of hyperventilation in blood donation-related vasovagal reactions and whether breathing is influenced by two treatments (alone and in combination) for reactions. The study will examine the clinical impact of these treatments but this is not the primary goal of the project.
Masking
None (open label)
Enrolment
408 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03159156
Sponsor's protocol ID
MOP-133459
Status last verified
May 2017
First submitted
15 May 2017
Last updated
18 May 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Applied Tension in people with Syncope, Vasovagal, run by McGill University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 May 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Blaine Ditto, PhD (514-398-6097, blaine.ditto@mcgill.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in End Tidal CO2 (time frame: change in mean value during the pre-donation waiting period (registration to going to chair, approximately 30 minutes) to the mean value in the donation chair (approximately 15 minutes)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in